S
Starling Medical
An AI powered at home urine diagnostic remote patient monitoring platform
About Starling Medical
Starling Medical operates in the healthcare technology sector, focusing on innovative solutions for neurogenic bladder dysfunction. The company serves patients with neurogenic bladder issues, a condition where nerve damage impairs the ability to sense bladder fullness and urinate on command. This condition affects over 3 million people in the United States alone. The current standard treatment involves the lifelong use of intermittent urinary catheters, which carry significant risks such as urosepsis, renal failure, and even death. Starling Medical aims to address these challenges with its AI and technology-enabled platform, the UrinControl System.
The UrinControl System offers a modern alternative to traditional urinary catheters, leveraging artificial intelligence to provide better bladder management. This system aims to reduce the high hospitalization rates and improve the quality of life for patients. The business model revolves around selling this advanced medical device and associated services to healthcare providers and directly to patients. Revenue is generated through the sale of the UrinControl System and possibly through subscription-based services for ongoing support and updates.
Starling Medical operates in a niche but critical market, targeting a specific patient demographic that faces severe health risks without proper bladder management. By offering a technologically advanced solution, the company positions itself as a leader in this specialized healthcare segment.
Source: Dealroom company dataNews
Open roles
Starling Medical in the Houston ecosystem
The Starling Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Texas A&M New Ventures Competition
Rebel Fund
Y Combinator
Series A1 investor entered at this stage
Tech.Bio
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Starling Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Starling Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


